Chemistry Advisory Board
Our chemistry advisors are well-respected experts in their fields. Their insights have been and continue to be invaluable as we work to develop therapies to address synaptic dysfunction.
- Martin Jefson, Ph.D., Chairman
Former Head of CNS Research, Pfizer
Founding CSO of Rodin
- William Greenlee, Ph.D.
Former Senior Director of Chemistry, Merck Research Laboratories
Former Vice President of Chemistry, Schering-Plough Research Institute
- John Lowe, Ph.D.
Former Senior Research Fellow, Pfizer
Founder and Consultant, JL3 Pharma
- John McCall, Ph.D.
Chairman of the Board and Vice President of Chemistry, ReveraGen BioPharma
Former Vice President and Global Head of Chemistry, Pharmacia and Pharmacia & Upjohn
- Neil Moss, Ph.D.
Former Director of Medicinal Chemistry, Boehringer Ingelheim
Medicinal Chemistry Consultant, Drug Discovery Solutions
Scientific Advisory Board
Our scientific advisors are pioneering leaders in neuroscience research. Their insights have been foundational to Rodin’s work.
- Li-Huei Tsai, Ph.D.
Director, Picower Institute for Learning and Memory
- Marcelo Wood, Ph.D.
Associate Professor and Chair, University of California, Irvine
- Lisa Monteggia, Ph.D.
Barlow Family Director, Vanderbilt Brain Institute
- Ed Holson, Ph.D.
Chief Scientific Officer, Amathus Therapeutics
- Stephen Haggarty, Ph.D.
Assistant Professor of Neurology, Harvard Medical School
- André Fischer, Ph.D.
Professor of Epigenetics in Brain Diseases, University Medical Center Göttingen
- Hans Moebius, M.D., Ph.D.
Board Certified Neurologist and Psychiatrist and Veteran R&D Leader
- David Bleakman, Ph.D.
Former Vice President and Chief Scientific Officer of Neuroscience Research, Eli Lilly